Key stakeholders
These are the current top-level decision-makers at the company and their LinkedIn profiles. Check them for recent activity and updates
Latest news about Zoetis
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
Zoetis reported strong Q3 2024 results, with a record quarterly revenue of $2.39 billion, exceeding analysts' estimates, and non-GAAP EPS of $1.58, surpassing the consensus estimate of $1.46. The company raised its full-year 2024 guidance to $9.20-$9.30 billion in revenue and $5.86-$5.92 in adjusted EPS[1][3].
Zoetis recently received approvals for several products, including Apoquel® Chewable in China and an additional claim for Revolution® Plus in the EU. The company also expanded its India Capability Center to drive digital transformation and advance animal care. Zoetis participated in the Piper Sandler 36th Annual Healthcare Conference on December 3, 2024, with CFO Wetteny Joseph engaging in a Q&A session[1][2][4].
Zoetis announced major leadership changes, including the appointment of Jamie Brannan as Chief Commercial Officer, Wafaa Mamilli's planned departure in early 2025, Keith Sarbaugh's promotion to EVP and Chief Digital & Technology Officer, and Jared Shriver's promotion to President, U.S. Operations, to accelerate long-term growth and optimize global operations[1].
Open job positions at Zoetis
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.
Scientist / Senior Scientist
Laboratory Technician – Chemistry Control Laboratory
CDD Responsable Comptes Clients Ruminants Région Est